Cargando…

Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients

BACKGROUND: Familial Adenomatous Polyposis (FAP) is caused by germline mutations in the APC (Adenomatous Polyposis Coli) gene. The vast majority of APC mutations are point mutations or small insertions / deletions which lead to truncated protein products. Splicing mutations or gross genomic rearrang...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihalatos, Markos, Apessos, Angela, Dauwerse, Hans, Velissariou, Voula, Psychias, Aristidis, Koliopanos, Alexander, Petropoulos, Konstantinos, Triantafillidis, John K, Danielidis, Ioannis, Fountzilas, George, Agnantis, Niki J, Nasioulas, Georgios
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1097718/
https://www.ncbi.nlm.nih.gov/pubmed/15833136
http://dx.doi.org/10.1186/1471-2407-5-40
_version_ 1782123909791875072
author Mihalatos, Markos
Apessos, Angela
Dauwerse, Hans
Velissariou, Voula
Psychias, Aristidis
Koliopanos, Alexander
Petropoulos, Konstantinos
Triantafillidis, John K
Danielidis, Ioannis
Fountzilas, George
Agnantis, Niki J
Nasioulas, Georgios
author_facet Mihalatos, Markos
Apessos, Angela
Dauwerse, Hans
Velissariou, Voula
Psychias, Aristidis
Koliopanos, Alexander
Petropoulos, Konstantinos
Triantafillidis, John K
Danielidis, Ioannis
Fountzilas, George
Agnantis, Niki J
Nasioulas, Georgios
author_sort Mihalatos, Markos
collection PubMed
description BACKGROUND: Familial Adenomatous Polyposis (FAP) is caused by germline mutations in the APC (Adenomatous Polyposis Coli) gene. The vast majority of APC mutations are point mutations or small insertions / deletions which lead to truncated protein products. Splicing mutations or gross genomic rearrangements are less common inactivating events of the APC gene. METHODS: In the current study genomic DNA or RNA from ten unrelated FAP suspected patients was examined for germline mutations in the APC gene. Family history and phenotype were used in order to select the patients. Methods used for testing were dHPLC (denaturing High Performance Liquid Chromatography), sequencing, MLPA (Multiplex Ligation – dependent Probe Amplification), Karyotyping, FISH (Fluorescence In Situ Hybridization) and RT-PCR (Reverse Transcription – Polymerase Chain Reaction). RESULTS: A 250 Kbp deletion in the APC gene starting from intron 5 and extending beyond exon 15 was identified in one patient. A substitution of the +5 conserved nucleotide at the splice donor site of intron 9 in the APC gene was shown to produce frameshift and inefficient exon skipping in a second patient. Four frameshift mutations (1577insT, 1973delAG, 3180delAAAA, 3212delA) and a nonsense mutation (C1690T) were identified in the rest of the patients. CONCLUSION: Screening for APC mutations in FAP patients should include testing for splicing defects and gross genomic alterations.
format Text
id pubmed-1097718
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-10977182005-05-12 Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients Mihalatos, Markos Apessos, Angela Dauwerse, Hans Velissariou, Voula Psychias, Aristidis Koliopanos, Alexander Petropoulos, Konstantinos Triantafillidis, John K Danielidis, Ioannis Fountzilas, George Agnantis, Niki J Nasioulas, Georgios BMC Cancer Research Article BACKGROUND: Familial Adenomatous Polyposis (FAP) is caused by germline mutations in the APC (Adenomatous Polyposis Coli) gene. The vast majority of APC mutations are point mutations or small insertions / deletions which lead to truncated protein products. Splicing mutations or gross genomic rearrangements are less common inactivating events of the APC gene. METHODS: In the current study genomic DNA or RNA from ten unrelated FAP suspected patients was examined for germline mutations in the APC gene. Family history and phenotype were used in order to select the patients. Methods used for testing were dHPLC (denaturing High Performance Liquid Chromatography), sequencing, MLPA (Multiplex Ligation – dependent Probe Amplification), Karyotyping, FISH (Fluorescence In Situ Hybridization) and RT-PCR (Reverse Transcription – Polymerase Chain Reaction). RESULTS: A 250 Kbp deletion in the APC gene starting from intron 5 and extending beyond exon 15 was identified in one patient. A substitution of the +5 conserved nucleotide at the splice donor site of intron 9 in the APC gene was shown to produce frameshift and inefficient exon skipping in a second patient. Four frameshift mutations (1577insT, 1973delAG, 3180delAAAA, 3212delA) and a nonsense mutation (C1690T) were identified in the rest of the patients. CONCLUSION: Screening for APC mutations in FAP patients should include testing for splicing defects and gross genomic alterations. BioMed Central 2005-04-15 /pmc/articles/PMC1097718/ /pubmed/15833136 http://dx.doi.org/10.1186/1471-2407-5-40 Text en Copyright © 2005 Mihalatos et al; licensee BioMed Central Ltd.
spellingShingle Research Article
Mihalatos, Markos
Apessos, Angela
Dauwerse, Hans
Velissariou, Voula
Psychias, Aristidis
Koliopanos, Alexander
Petropoulos, Konstantinos
Triantafillidis, John K
Danielidis, Ioannis
Fountzilas, George
Agnantis, Niki J
Nasioulas, Georgios
Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients
title Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients
title_full Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients
title_fullStr Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients
title_full_unstemmed Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients
title_short Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients
title_sort rare mutations predisposing to familial adenomatous polyposis in greek fap patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1097718/
https://www.ncbi.nlm.nih.gov/pubmed/15833136
http://dx.doi.org/10.1186/1471-2407-5-40
work_keys_str_mv AT mihalatosmarkos raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT apessosangela raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT dauwersehans raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT velissariouvoula raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT psychiasaristidis raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT koliopanosalexander raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT petropouloskonstantinos raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT triantafillidisjohnk raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT danielidisioannis raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT fountzilasgeorge raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT agnantisnikij raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients
AT nasioulasgeorgios raremutationspredisposingtofamilialadenomatouspolyposisingreekfappatients